The molecule
Brazil fought for.
In the 1990s, inside a laboratory at the University of São Paulo, a small team of chemists synthesized a bioidentical form of phosphoethanolamine. The people who received it began to report a change in how they felt. The press gave it a name that swept across a country: "the cancer pill."
Born in a USP laboratory
At the Institute of Chemistry of São Carlos, chemist Gilberto Chierice and his team synthesize bioidentical phosphoethanolamine and begin studying its effect on cellular metabolism.
Passed hand to hand
Shared quietly with people who reported improvements in their wellbeing. With no marketing, word travelled across Brazil — family to family, story to story.
A nation divided
Public pressure reached the highest courts. Law 13.269/2016 briefly authorized its use before the Supreme Court suspended it — a chapter that turned a molecule into a movement.
The original, safeguarded
Of the original team, a single chemist remains. He works with America Nutrition to keep ImunoFosfo faithful to the original formula — produced in an FDA-registered lab, with a toxicology report on every batch.
ImunoFosfo is a dietary supplement based on synthetic bioidentical phosphoethanolamine. The history above is shared for context and heritage. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease, and does not replace medical care.
